Zenotech Laboratories Reports Widened Net Loss of ₹257.33 Lakh in Q2 FY27
Zenotech Laboratories Ltd · Outcome · 28 Oct 2026, 7:56 pm
Zenotech Laboratories Reports Widened Net Loss of ₹257.33 Lakh in Q2 FY27 Zenotech Laboratories reported standalone revenue from operations of ₹613.15 lakh for the quarter ended 30th Sep'26, down 40.07% YoY from ₹1,023.19 lakh and down 36.11% QoQ from ₹959.64 lakh. Total income stood at ₹757.15 lakh versus ₹1,193.64 lakh in Q2 FY26. Net loss widened significantly to ₹257.33 lakh compared to a loss of ₹83.65 lakh in Q2 FY26 and a loss of ₹45.55 lakh in Q1 FY27, resulting in an EPS of negative ₹0.42. For H1 FY27, net loss reached ₹302.88 lakh.
Original exchange filing (PDF)
More announcements from Zenotech Laboratories Ltd
- Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 28 Oct 2026
- Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Unaudited Standalone .... · 28 Oct 2026
- Voting Results and Scrutinizer Report of 37th Annual General Meeting of the Company held on September 25, 2026. · 26 Sept 2026
- Outcome of the 37th Annual General Meeting of the Company held on Friday, September 25, 2026. · 25 Sept 2026
- Notice of 37th Annual General Meeting along with Annual Report for the FY 2025-26 · 28 Aug 2026
- Annual Report 2025-26 and the Notice of 37th Annual General Meeting · 28 Aug 2026
- Intimation of 37th Annual General Meeting of the Company to be held on Friday, September 25, 2026 at 10:30 a.m. IST through Video Conferencing mode. · 22 Aug 2026
- Outcome of the Board Meeting held today, i.e., July 28, 2026 · 28 Jul 2026
